Pharmakologische Aspekte therapeutischer Botulinum-Toxin-Präparationen

No abstract is available for this paper.

• Publication year

  2006

• Venue

  Der Nervenarzt

• Publication date

  2006-08-01

• Fields of study

  Not labeled

• Identifiers
  DOI 10.1007/s00115-006-2090-2
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar

• No claims are published for this paper.

• No concepts are published for this paper.

• Immunological aspects of Botox®, Dysport® and MyoblocTM/NeuroBloc®

  2006cited by this paper
• A new botulinum toxin type A free of complexing proteins for treatment of cervical dystonia

  2005cited by this paper
• Botulinum toxin type B de novo therapy of cervical dystonia

  2005cited by this paper
• 125I-Labelled botulinum a neurotoxin: Pharmacokinetics in cats after intramuscular injection

  2004cited by this paper
• Comparison of efficacy and immunogenicity of original versus current botulinum toxin in cervical dystonia

  2003cited by this paper
• Autonomic Side Effects of Botulinum Toxin Type B Treatment of Cervical Dystonia and Hyperhidrosis

  2002cited by this paper
• Magnetic resonance imaging in

  2002cited by this paper
• Botulinum toxin type B for treatment of axillar hyperhidrosis

  2002cited by this paper
• Inhibition of gastric emptying and small intestinal transit by ethanol is mediated by capsaicin-sensitive afferent nerves

  2001cited by this paper
• Differential inhibition by botulinum neurotoxin A of cotransmitters released from autonomic vasodilator neurons.

  2001cited by this paper
• The biochemistry of botulinum toxin type B.

  2000cited by this paper
• Electromyographic Quantification of the Paralysing Effect of Botulinum Toxin in the Sternocleidomastoid Muscle

  2000cited by this paper
• Sensitivity of embryonic rat dorsal root ganglia neurons to Clostridium botulinum neurotoxins.

  2000cited by this paper
• Capsaicin-stimulated release of substance P from cultured dorsal root ganglion neurons: involvement of two distinct mechanisms.

  2000cited by this paper
• The sternocleidomastoid test: an in vivo assay to investigate botulinum toxin antibody formation in humans

  2000cited by this paper
• [Presynaptic effects of botulinum toxin type A on the neuronally evoked response of albino and pigmented rabbit iris sphincter and dilator muscles].

  2000cited by this paper
• Tetanus and botulinum neurotoxins: mechanism of action and therapeutic uses.

  1999cited by this paper
• Functional repair of motor endplates after botulinum neurotoxin type A poisoning: biphasic switch of synaptic activity between nerve sprouts and their parent terminals.

  1999cited by this paper
• Extrafusal and intrafusal muscle effects in experimental botulinum toxin‐A injection

  1996cited by this paper
• Botulinum neurotoxin C1 cleaves both syntaxin and SNAP-25 in intact and permeabilized chromaffin cells: correlation with its blockade of catecholamine release.

  1996cited by this paper
• Muscle afferent block by intramuscular injection of lidocaine for the treatment of writer's cramp

  1995cited by this paper
• Tonic vibration reflex and muscle afferent block in writer's cramp

  1995cited by this paper
• Proteolysis of SNAP-25 by types E and A botulinal neurotoxins.

  1994cited by this paper
• Cleavage of members of the synaptobrevin/VAMP family by types D and F botulinal neurotoxins and tetanus toxin.

  1994cited by this paper
• Botulinum neurotoxins serotypes A and E cleave SNAP‐25 at distinct COOH‐terminal peptide bonds

  1993cited by this paper
• Systemic effect of local botulinum toxin injections unmasks subclinical Lambert-Eaton myasthenic syndrome.

  1993cited by this paper
• Botulinum A toxin effects on rat jaw muscle spindles.

  1993cited by this paper
• Tetanus and botulinum-B neurotoxins block neurotransmitter release by proteolytic cleavage of synaptobrevin

  1992cited by this paper
• Tetanus toxin and botulinum toxins type A and B inhibit glutamate, gamma-aminobutyric acid, aspartate, and met-enkephalin release from synaptosomes. Clues to the locus of action.

  1992cited by this paper
• Inhibition of calcium-dependent release of noradrenaline from PC12 cells by botulinum type-A neurotoxin. Long-term effects of the neurotoxin on intact cells.

  1992cited by this paper
• Botulinum toxin therapy: distant effects on neuromuscular transmission and autonomic nervous system.

  1992cited by this paper
• Botulinum toxin therapy.

  1991cited by this paper
• [Botulinum toxin in therapy of craniocervical dystonia].

  1989cited by this paper
• Neuromuscular effects distant from the site of botulinum neurotoxin injection

  1988cited by this paper
• Distant effects of local injection of botulinum toxin

  1987cited by this paper
• TLC immunostaining characterization of Clostridium botulinum type A neurotoxin binding to gangliosides and free fatty acids

  1986cited by this paper
• Botulinum toxin for blepharospasm: single-fiber EMG studies

  1986cited by this paper
• Botulinum toxin injection into extraocular muscles as an alternative to strabismus surgery.

  1980cited by this paper
• Effects of type a botulinum toxin on the cholinergic transmission at spinal renshaw cells and on the inhibitory action at ia inhibitory interneurones

  1977cited by this paper
• Pharmacologic weakening of extraocular muscles.

  1973cited by this paper
• Changes in the electron microscopic structure of slow and fast skeletal muscle fibres of the mouse after the local injection of botulinum toxin.

  1971cited by this paper
• An electron microscopic study of the changes induced by botulinum toxin in the motor end-plates of slow and fast skeletal muscle fibres of the mouse.

  1971cited by this paper
• An intracellular study of the action of repetitive nerve volleys and of botulinum toxin on miniature end‐plate potentials

  1956cited by this paper
• The action of botulinum toxin on motor‐nerve filaments

  1954cited by this paper
• Motor nerve filament block produced by botulinum toxin.

  1953cited by this paper
• The action of botulinum toxin on the neuro‐muscular junction

  1949cited by this paper
• Ueber einen neuen anaëroben Bacillus und seine Beziehungen zum Botulismus

  1897cited by this paper
• Neue Beobachtungen über die in Würtemberg so häufig vorfallenden tödtlichen Vergiftungen durch den Genuß geräucherter Würste

  year unknowncited by this paper

• The Immunology of Botulinum Toxin Therapy: A Brief Summary.

  2022cites this paper
• Kiefergelenkchirurgie

  2021cites this paper
• Neurotoxin Impurities: A Review of Threats to Efficacy

  2020cites this paper
• Schritt für Schritt erklärt

  2018cites this paper
• History of Botulinum Toxin for Medical and Aesthetic Use

  2017cites this paper
• Botulinumtoxin — ein Neuromodulator zur effektiven Therapie von Depression?

  2015cites this paper
• Botulinum Toxin A in the Treatment of Oropharyngeal or Esophageal Dysphagia

  2013cites this paper
• A comparative, prospective, split-face, blind study of the efficacy of two botulinum toxin type A drugs (Disport® and Xeomin®) used to correct lateral periorbital wrinkles

  2013cites this paper
• Botulinum toxin immunoresistance in dystonia medical application

  2012cites this paper
• Wirkung von Botulinumtoxin Typ B auf Stumpfschwitzen und Stumpfschmerzen Besteht die Chance der indirekten Phantomschmerzreduktion durch bessere Prothesennutzung

  2012cites this paper
• Five‐year experience with incobotulinumtoxinA (Xeomin®): the first botulinum toxin drug free of complexing proteins

  2012cites this paper
• Wirkung von Botulinumtoxin Typ B auf Stumpfschwitzen und Stumpfschmerzen

  2012cites this paper
• Botulinum toxin therapy for cervical dystonia: review of the clinical evidence and ongoing studies

  2011cites this paper
• Botulinumtoxin Typ A im Halbseitenvergleich

  2011cites this paper
• Dystonien mit Beteiligung der mastikatorischen Muskulatur : eine retrospektive Analyse

  2011cites this paper
• Botulinum Toxin for Glabellar Lines

  2011cites this paper
• Noncosmetic Periocular Therapeutic Applications of Botulinum Toxin

  2010cites this paper
• Comparing Botox® and Xeomin® for axillar hyperhidrosis

  2010cites this paper
• Botulinum toxin in facial rejuvenation: an update.

  2010cites this paper
• Complexing proteins in botulinum toxin type A drugs: a help or a hindrance?

  2010cites this paper
• Use of botulinum toxin in the neurology clinic

  2010cites this paper
• Paralysierende Gesichtsfaltenbehandlung mit Botulinumtoxin

  2009cites this paper
• Clinical Comparability of Dysport and Botox in Essential Blepharospasm

  2009cites this paper
• Chapter 32 – Properties of Pharmaceutical Products of Botulinum Neurotoxins

  2009cites this paper
• Botulinum toxin in facial rejuvenation: an update.

  2009cites this paper
• Improved intramuscular blood flow and normalized metabolism in lateral epicondylitis after botulinum toxin treatment

  2009cites this paper
• Behandlung der Kaumuskelhypertrophie mit Botulinumtoxin

  2009cites this paper
• 23 Speekselovervloed: sialorroe en hypersalivatie

  2008cites this paper
• Successful treatment of tardive lingual dystonia with botulinum toxin: case report and review of the literature.

  2008cites this paper
• Botulinum Toxin for Pelvic Pain in Women

  2008cites this paper
• Overview of Botulinum Toxin

  2007cites this paper
• Botulinum toxin: description of injection techniques and examination of controversies surrounding toxin diffusion

  2007cites this paper
• Palmar and plantar hyperhidrosis: a practical management algorithm

  2007cites this paper